Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Malignant Neoplasm
76%
Neoplasm
74%
Cytotoxicity
64%
Clinical Trial
50%
Nanoparticle
39%
Gold Nanoparticle
38%
Gene Delivery
32%
Reactive Oxygen Metabolite
30%
Adenovirus Vector
19%
Thymidine Kinase
19%
Combination Therapy
16%
Prostate Carcinoma
16%
Laminaran
16%
Diseases
14%
Biodistribution
14%
Adenoviridae
14%
Anticarcinogen
13%
Long Term Survival
13%
Castration Resistant Prostate Cancer
12%
Hydrogen Peroxide
11%
Immunotherapy
11%
Elimination
11%
Tumor Regression
11%
Antioxidant
10%
Neurotoxicity
10%
G Protein Coupled Receptor
10%
Colorectal Carcinoma
10%
Caspase 8
9%
IC50
9%
Drug Release
9%
Anti-Inflammatory Drug
8%
Tumor Necrosis Factor Receptor Superfamily Member 6
8%
Recurrent Disease
8%
Mycosis
8%
Curcumin
8%
Stomach Tumor
8%
Synthetic Peptide
8%
Bioresponsive
8%
Laminaria
8%
Receptor
8%
Liposome
8%
In Vitro Screening
8%
Adenosine Triphosphate
8%
Preclinical Study
8%
Lung Cancer
8%
Salmonella
8%
Amino Acid
8%
Fibrinogen
8%
Hydration
8%
Immunology and Microbiology
Blood Plasma
66%
Adenovirus Vector
54%
Transgene
43%
Cell Death
42%
Adenoviridae
32%
Cytotoxicity
30%
Glioma Cell
26%
Immune Response
26%
CD135 Antigen
24%
T Cell
23%
Human Alphaherpesvirus 1
22%
Tyrosine
15%
Syngenic
15%
Long Term Survival
15%
Lysosome
13%
Parenchyma
13%
Regulatory T Cell
12%
Immune System
11%
Immunotherapy
11%
Caspase
11%
Helper Dependent Adenoviral Vector
11%
Gene Expression
11%
Survival Rate
10%
Tumor Cell
10%
Autoimmunity
10%
Solution and Solubility
9%
Hydrogen Peroxide
9%
Astrocyte
9%
Cancer Cell
9%
Immune Privilege
9%
Dendritic Cell
9%
Scanning Electron Microscopy
9%
Electric Potential
9%
Promoter Region
9%
Aspergillus Niger
9%
Gene Targeting
9%
Biological Activity
9%
Real Time Polymerase Chain Reaction
8%
Cancer Stem Cell
8%
Biofilm
8%
Salmonella
8%
Surface Plasmon Resonance
8%
Self Evaluation
8%
Foot
8%
Major Histocompatibility Complex
8%
Xenograft
8%
Cell Migration
8%
Neoantigen
8%
Lipid Peroxidation
8%
Gene Expression System
8%
Medicine and Dentistry
Glioblastoma
68%
Neoplasm
44%
Ganglioglioma
44%
Intracranial Tumor
41%
Gene Therapy
41%
Cytotoxicity
32%
Malignant Neoplasm
22%
Clinical Trial
20%
Carcinoma Cell
19%
Reactive Oxygen Species
18%
Cancer Cell
18%
Cell Death
17%
Prostate Carcinoma
16%
Endocytosis
16%
Programmed Cell Death
16%
Gold Nanoparticle
16%
Nanoparticle
16%
Tumor Regression
16%
T Cell
15%
Long Term Survival
13%
Anticarcinogen
12%
In Vitro
12%
Gene Expression
11%
Cancer Immunotherapy
10%
Human Alphaherpesvirus 1
9%
Glioma Cell
9%
CD135 Antigen
9%
Diseases
9%
Immune Response
9%
Oncogene
8%
Lysosome
8%
Complex Formation
8%
Death Domain Receptor Signaling Adaptor Protein
8%
Lung Cancer
8%
Mycosis
8%
Infrared Imaging
8%
Surface-Enhanced Raman Spectroscopy
8%
Cytotoxic Chemotherapy
8%
B Cell
8%
Clathrin
8%
Quinazoline
8%
G Protein Coupled Receptor 120
8%
Antioxidant
8%
Cell Culture
8%
IC50
8%
Adenosine Triphosphate
8%
In Silico
8%
In Vitro Screening
8%
Cancer Stem Cell
8%
Cyclopentane
8%
